Leica Biosystems, unveiled ChromoPlex III Triple Detection RUO, a chromogenic multiplex immunohistochemistry detection system engineered to simplify assay setup and reduce variability. ChromoPlex III ...
Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the analysis of target protein expression in subsets of specific cells within the context of ...
Leica Biosystems will develop a fully automated HER2 diagnostic to support identification of appropriate HER2 negative (IHC 1+/2+) patients for NeuVax™ (nelipepimut-S or E75) Galena strengthens its ...
Please join Leica Biosystems Life Science Field Applications Specialist Mark Lawson for this special event, where Mark shares the development timeline of IHC and multiplex staining on the BOND RX ...
(MENAFN- PR Newswire) The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, United Kingdom, April 3, 2023 ...
Simplify your research in cancer biology and discover new approaches to diagnosis with the new BOND RX next generation research stainer by Leica Biosystems. The BOND RX system provides researchers ...
SAN DIEGO, Nov. 8, 2022 /PRNewswire/ -- Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging, has acquired Cell IDx, Inc., a leader in multiplexed tissue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback